Aurobindo Pharma Signs Pact To Sell U.S. Unit Natrol For $550 Million

Analysts see Aurobindo Pharma Ltd.’s move to sell a wholly owned subsidiary of its U.S. arm as lucrative, with surplus cash and reduced debt strengthening its balance sheet.The Indian drugmaker has...